TBC1D22B-FGD2 Fusion FISH Probe
The TBC1D22B-FGD2 Fusion FISH Probe is used to confirm a fusion of the TBC1D22B and FGD2 genes. The fusion of the TBC1D22B and FGD2 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TBC1D22B-FGD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22B-FGD2-20-AQAQ | 20 (40 μL) | 200 μL |
|
TBC1D22B Gene Summary
The TBC1 Domain Family Member 22B (TBC1D22B) gene is located on chr6 :37225547-37300746 at 6p21.2.
Gene Name: TBC1 Domain Family Member 22B
Chromosome: CHR6: 37225547 -37300746
Locus: 6p21.2
FGD2 Gene Summary
The protein encoded by this gene belongs to a family of guanine nucleotide exchange factors (GEFs) which control cytoskeleton-dependent membrane rearrangements by activating the cell division cycle 42 (CDC42) protein. This gene is expressed in B lymphocytes, macrophages, and dendritic cells. The encoded protein may play a role in leukocyte signaling and vesicle trafficking in antigen-presenting cells in the immune system. [provided by RefSeq, Oct 2016]
Gene Name: FYVE, RhoGEF And PH Domain Containing 2
Chromosome: CHR6: 36973422 -36996845
Locus: 6p21.2
Gene Diseases
The TBC1D22B FGD2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|